Content by Mount Sinai School of Medicine

|3 min read

New AI Tool Identifies Not Just Genetic Mutations, but the Diseases They May Cause

The method, called V2P, uses advanced machine learning to link genetic variants with their likely phenotypic outcomes
|3 min read

Experimental mRNA Therapy Shows Potential to Combat Antibiotic-Resistant Infections

Preclinical studies show mRNA therapy slows antibiotic-resistant bacteria and enhances immune response
|4 min read

Mount Sinai Health System Among First to Use Blood Tests for Early Alzheimer’s Detection

Mount Sinai Health System among the first in the world to use blood tests as an early detection tool for Alzheimer’s disease and related dementias in patients
|2 min read

Can AI Help Improve ER Admission Decisions?

A new study from Mount Sinai used data from than 864,000 emergency room visits to assess GPT-4’s ability to predict hospital admissions
|3 min read

Novel Genes That May Increase Schizophrenia Risk Identified

The largest known study of its kind also shows the risk is shared across ethnicities

|3 min read

Experimental Cancer Therapy Shows Success in More than 70% of Patients

Directs patients’ immune system to kill multiple myeloma cells
|3 min read

Study Links Molecular Changes to Long COVID a Year after Hospitalization

Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19
|2 min read

Genes to Potentially Diagnose Long-Term Lyme Disease Identified

Findings could lead to new diagnostics and treatments for the hard-to-detect condition
|3 min read

Employee Health Contact Tracing Database Helps Enhance Safety

Digital framework serves as model for large health systems during future pandemics
|2 min read

Treating Lung Disease in Patients Who Received New Drug for Advanced Cancer

Close monitoring and proactive management could reduce the risk of lung disease
|3 min read

Black Patients More Likely to Have Advanced Vision Loss after Glaucoma Diagnosis

Black patients had a sixfold higher risk for advanced field loss archetypes, when compared to White patients
Page 1 of 2